3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Stomach Neoplasms
10
Carcinoma, Hepatocellular
10
Carcinoma, Non-Small-Cell Lung
5
Rectal Neoplasms
3
Esophageal Squamous Cell Carcinoma
3
Recurrence
2
Nasopharyngeal Carcinoma
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Turcot syndrome
1
Thyroid Neoplasms
1
Squamous Non-Small Cell Lung Cancer SqNSCLC
1
Spinocerebellar Degenerations
1
Solid Tumor
1
Small Cell Lung Carcinoma
1
Resectable Non-small Cell Lung Cancer
1
Rare Tumour
1
Pancreatic Neoplasms
1
Pancreatic Cancer Resectable
1
Pancreatic Cancer Metastatic
1
Neoplasms
1
Neoplasm Metastasis
1
Lymphoma, Large B-Cell, Diffuse
1
Lung Neoplasms
1
Locally Advanced Non-Small Cell Lung Cancer
1
Hodgkin Disease
1
HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
1
Esophageal Neoplasms
1
Interventions
spartalizumab
1
sintilimab
1
pyrotinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Advanced Digestive System Tumor
×
sintilimab
×
Clear all
NCT07053150
2025-07-08
CCGLC-018
Tongji Hospital
Phase 2
Not yet recruiting
80 enrolled